Diffuse Intrinsic Pontine Glioma: New Pathophysiological Insights and Emerging Therapeutic Targets - Test2 - elhamkhani - TriplyDB

Diffuse Intrinsic Pontine Glioma: New Pathophysiological Insights and Emerging Therapeutic Targets

Diffuse Intrinsic Pontine Glioma: New Pathophysiological Insights and Emerging Therapeutic Targets

http://www.wikidata.org/entity/Q30251385

about

A Protocol for Rapid Post-mortem Cell Culture of Diffuse Intrinsic Pontine Glioma (DIPG).Genetic and immune features of resectable malignant brainstem gliomas.REST upregulates gremlin to modulate diffuse intrinsic pontine glioma vasculature.Importance of immune monitoring approaches and the use of immune checkpoints for the treatment of diffuse intrinsic pontine glioma: From bench to clinic and vice versa (Review).Non-inflammatory tumor microenvironment of diffuse intrinsic pontine glioma.Combined use of CDK4/6 and mTOR inhibitors induce synergistic growth arrest of diffuse intrinsic pontine glioma cells via mutual downregulation of mTORC1 activity CSF H3F3A K27M circulating tumor DNA copy number quantifies tumor growth and in vitro treatment response

P2860

Q33615351-039DCFD8-082C-4971-A372-47E402A88436 Q47152219-7EE7D1DF-EC83-4B3B-B24B-4F92D3003F2A Q49562927-00B81199-2756-408B-B1A2-570B9AAED988 Q52683991-BE7A1405-02AC-4310-8B63-3D9B86830A29 Q55456543-162B3176-0A17-4AAF-95E8-0380772A65A1 Q58746764-80304201-5AEB-4112-A1C5-D9C0579D3348 Q58778001-158D542F-1319-48E6-99F8-8304AF7B5FEE

P2860

Diffuse Intrinsic Pontine Glioma: New Pathophysiological Insights and Emerging Therapeutic Targets

http://www.wikidata.org/entity/Q30251385

description

2016 nî lūn-bûn

@nan

2016 թուականի Մայիսին հրատարակուած գիտական յօդուած

@hyw

2016 թվականի մայիսին հրատարակված գիտական հոդված

@hy

2016年の論文

@ja

2016年論文

@yue

2016年論文

@zh-hant

2016年論文

@zh-hk

2016年論文

@zh-mo

2016年論文

@zh-tw

2016年论文

@wuu

name

Diffuse Intrinsic Pontine Glio ...... d Emerging Therapeutic Targets

@ast

Diffuse Intrinsic Pontine Glio ...... d Emerging Therapeutic Targets

@en

type

label

Diffuse Intrinsic Pontine Glio ...... d Emerging Therapeutic Targets

@ast

Diffuse Intrinsic Pontine Glio ...... d Emerging Therapeutic Targets

@en

prefLabel

Diffuse Intrinsic Pontine Glio ...... d Emerging Therapeutic Targets

@ast

Diffuse Intrinsic Pontine Glio ...... d Emerging Therapeutic Targets

@en

P1433

Q30251385-1294C7F2-75CF-4C98-886F-607C17BAC035

P1476

Q30251385-C163FD21-A33D-418A-9B16-CD034DD0DE87

P2093

Q30251385-0FA23522-6BCC-468B-9800-CFE653A91FB8

P275

Q30251385-DA76FA94-0CBF-461E-8F7A-F6D6EEA53BF9

P2860

Q30251385-00DD8C70-7545-4C47-808D-74E06B14DC12

Q30251385-02092E71-2849-4261-BCEE-1C96C7FB52D6

Q30251385-03B3066B-3881-4583-BD94-B3AC11D22BF8

Q30251385-0470D579-A8DA-4CF3-B9B0-BEDE3852FF59

Q30251385-04DF802E-76EB-4DEF-B75B-126BF7AD11BD

Q30251385-08137ECA-E5AE-4B4D-9868-498D0F153C8B

Q30251385-0F07CF72-E464-411A-95DD-98AB72B74CD7

Q30251385-104628B3-5306-45E8-B10F-DE008CA08DAC

Q30251385-125A8ADB-7D85-41B5-A597-568EAE02D83F

Q30251385-1B7DF736-B5F4-4CCE-9258-16CB435B57E2

P304

Q30251385-47A45D86-6173-4C07-8B90-9A79233F9CCE

P31

Q30251385-3FE0C039-B2EB-4390-A3F4-551464FE8372

Q30251385-B94BFCA9-D262-452F-874F-79430C356C89

P356

Q30251385-7CD34C82-95EA-48C8-915C-EBF195AFE5FD

P433

Q30251385-12EA74D7-AC3C-4CDE-A5EE-225C14DFDAB0

P478

Q30251385-6A9D073D-AFF0-4149-A8F8-AE6E9F0AC50B

P50

Q30251385-D68FB26E-708F-40C7-90E1-8A64693B7726

P5008

Q30251385-E7BEBD9B-06D3-4152-AB93-C62B7E16A73A

P577

Q30251385-758CE302-A8BD-420A-AEE1-10DC07D13510

P698

Q30251385-5BF56F4A-966E-4E04-8BD4-8AD8469BEC6D

P921

Q30251385-2317F6A0-0B1A-4A87-BDEC-B8C06358C08D

Q30251385-24CFAD0C-9CDD-4AF4-8361-5B6E49F5FEFE

Q30251385-B739AAA2-31B0-4E5E-8D45-F5F639D64471

Q30251385-D49B6717-FD34-4D64-977F-2E3B072F9DAF

P932

Q30251385-6E3DE3A1-B0F9-4CF3-A65A-D4286C8A0EFB

P356

1570159X14666160509123229

P1433

Current Neuropharmacology

P1476

Diffuse Intrinsic Pontine Glio ...... d Emerging Therapeutic Targets

@en

P2093

Tessa B Johung

http://www.w3.org/2001/XMLSchema#string

P275

Creative Commons Attribution-NonCommercial

P2860

A recurrent mutation in the BMP type I receptor ACVR1 causes inherited and sporadic fibrodysplasia ossificans progressiva

Reduced H3K27me3 and DNA hypomethylation are major drivers of gene expression in K27M mutant pediatric high-grade gliomas

K27M mutation in histone H3.3 defines clinically and biologically distinct subgroups of pediatric diffuse intrinsic pontine gliomas

Somatic histone H3 alterations in pediatric diffuse intrinsic pontine gliomas and non-brainstem glioblastomas

Epigenetic dysregulation: a novel pathway of oncogenesis in pediatric brain tumors

Every amino acid matters: essential contributions of histone variants to mammalian development and disease

Neuronal Activity Promotes Glioma Growth through Neuroligin-3 Secretion

Binding of different histone marks differentially regulates the activity and specificity of polycomb repressive complex 2 (PRC2)

Recurrent activating ACVR1 mutations in diffuse intrinsic pontine glioma

Genomic analysis of diffuse intrinsic pontine gliomas identifies three molecular subgroups and recurrent activating ACVR1 mutations

P304

88-97

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.2174/1570159X14666160509123229

http://www.w3.org/2001/XMLSchema#string

P433

1

http://www.w3.org/2001/XMLSchema#string

P478

15

http://www.w3.org/2001/XMLSchema#string

P50

P5008

P577

2016-05-09T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

27157264

http://www.w3.org/2001/XMLSchema#string

P921

pathophysiology

diffuse intrinsic pontine glioma

brain stem neoplasm

P932

5327455

http://www.w3.org/2001/XMLSchema#string